UNSPSC 85524089: Occlusion of right axillary vein with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of right axillary vein with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05L74DZ

UNSPSC 85524089 Occlusion of right axillary vein with intraluminal device, percutaneous endoscopic approach is a Commodity code that appears to describe a highly specific clinical procedure. However, the recent state and local contract opportunities tagged under this code bear no meaningful relationship to the code's nominal scope. The opportunities center on occupational health surveillance, disability benefit medical evaluations, surgical procedure carve-out networks for employee health plans, pharmacy benefit management, temporary clinical staffing, and emergency medical services for youth in custody—none of which involve axillary vein occlusion or intraluminal device placement. The code's present tagging by state and local procurement offices reflects a significant taxonomy mismatch rather than a coherent commodity family. State and local governments do purchase medical services and benefits administration at scale, but those activities are not usefully characterized or tracked through this particular code.

The source shows no recent opportunities with direct relevance to axillary vein occlusion procedures or comparable vascular interventions. The opportunities posted in August and September 2026 span Arizona, California, Washington, Texas, and Florida and include issuing bodies ranging from city retirement boards and county health systems to state transportation agencies and county juvenile probation departments. Until the code's tagging is corrected or realigned with actual procurement activity in this clinical specialty, the code provides no reliable signal for business development targeting state and local vascular or interventional medical device procurement.